(NewsDirect)
By Johnny Rice, Benzinga
Al Altomari, Chairmanand CEO of Agile Therapeutics Inc (NASDAQ: AGRX), was recentlyinterviewed by Benzinga.
Agile Therapeutics says it is a women's healthcare companydedicated to fulfilling the unmet health needs of today’s women. Itsproducts and product candidates are designed to provide women withcontraceptive options that offer freedom from taking a daily pill,without committing to a longer-acting method.
The company’s flagshipproduct is Twirla® (levonorgestrel and ethinyl estradiol), anon-daily prescription contraceptive utilizing a transdermal system.Twirla is based on proprietary transdermal patch technology, calledSkinfusion®, designed to allow drug delivery through the skin.
Watch the full interviewhere:
AgileTherapeutics is a women's healthcare company dedicated tofulfilling the unmet health needs of today’s women. Our product andproduct candidates are designed to provide women with contraceptiveoptions that offer freedom from taking a daily pill, withoutcommitting to a longer-acting method. Our initial product, Twirla®,(levonorgestrel and ethinyl estradiol), a transdermal system, is anon-daily prescription contraceptive. Twirla is based on ourproprietary transdermal patch technology, called Skinfusion®, whichis designed to allow drug delivery through the skin.
Thispost contains sponsored advertising content. This content is forinformational purposes only and is not intended to be investingadvice.
Contact Details
Matt Riley - Head ofInvestor Relations & Corporate Communications
CompanyWebsite
https://agiletherapeutics.com/
Copyright (c) 2023 TheNewswire - All rights reserved.